Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 11;4(1):e196.
doi: 10.1017/ash.2024.455. eCollection 2024.

Can risk factors and risk scores help predict colonization and infection in multidrug-resistant gram-negative bacteria?

Affiliations
Review

Can risk factors and risk scores help predict colonization and infection in multidrug-resistant gram-negative bacteria?

Natalia Restrepo-Arbeláez et al. Antimicrob Steward Healthc Epidemiol. .

Abstract

Antimicrobial resistance (AMR) is positioning as one of the most relevant threats to global public health and threatens the effective treatment of an ever-growing number of bacterial infections in various healthcare settings, particularly in acute care and surgical units, as well as in the community. Among multidrug-resistant (MDR) gram-negative bacteria (MDRGNB), Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii require special attention, since they account for most of the mortality associated with bacterial infections and are often MDR. It is clear that there is an important global variation in antibiotic resistance profiles among MDRGNB species. Extended-spectrum β-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, DTR-P. aeruginosa, and MDR-A. baumannii are the focus of this review. Here, we summarize a series of relevant studies on risk factors associated with colonization and infection with these MDRGNB. Likewise, we offer a comparative overview of those studies providing scoring systems to predict the risk of infection with these MDR pathogens, and their pros and cons. Despite the variable accuracy of published risk factors for predicting colonization or infection with MDRGNB, these scores are valuable tools that may help anticipate colonization and infection among those colonized. More importantly, they may help reduce unnecessary use of broad-spectrum antimicrobials and guiding the selection of an optimal treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships that may be considered as potential competing interests. M.V.V. and C.J.P have received honoraria and research grants from MSD, Pfizer, bioMérieux, West and GPC pharma. S.S.K has received honoraria for participating in advisory boards and as a speaker from MSD, Pfizer, GSK, and Menarini. P.K has received honoraria for participating in an advisory board from Pfizer and as a speaker from bioMérieux, MSD and Pfizer. The other authors declare no competing financial interest. All authors, except J.C.G.B, C.J.P, N.R.A, and L.W.A received an honorarium from Pfizer to attend a steering committee meeting to discuss their regional perspective on MDR gram-negative infections and AMS strategies. The output of these discussions was used to create to a framework for this manuscript prior to its development.

References

    1. Abayneh M, Worku T. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: a meta-analysis report in Ethiopia. Drug Target Insights 2020;14:16–25. - PMC - PubMed
    1. Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 2020;25:1340. - PMC - PubMed
    1. Exner M, Bhattacharya S, Christiansen B, et al. Antibiotic resistance: what is so special about multidrug-resistant gram-negative bacteria? GMS Hyg Infect Control 2017;12:Doc05. - PMC - PubMed
    1. Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics (Basel) 2020;9:196. - PMC - PubMed
    1. Santoro A, Franceschini E, Meschiari M, et al. Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: impact of MDR and XDR bacteria. Open Forum Infect Dis 2020;7:ofaa461. - PMC - PubMed

LinkOut - more resources